CXCL10 and amyotrophic lateral sclerosis: Since CsA and ALS iPSC-CM both improved mitochondria and reduced expression of INFB1, TNF, and IP-10, we compared them side-by-side for neuroprotection in diminishing apoptosis and improving the viability of human ALS-MNs.